Legend Biotech Net Debt Growth & History (LEGN)

Legend Biotech's net debt was −$488.2M for fiscal 2025.

View full Legend Biotech company overview

Legend Biotech annual net debt history

Legend Biotech annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$488.2M−$500.9M
20242024-12-31$12.7M$993.1M
20232023-12-31−$980.4M−$468.0M
20222022-12-31−$512.4M$54.3M
20212021-12-31−$566.7M−$114.4M
20202020-12-31−$452.3M−$375.0M
20192019-12-31−$77.3M

Legend Biotech net debt trends

Over the last five fiscal years, Legend Biotech's net debt decreased from −$452.3M to −$488.2M, a change of −$35.9M. The latest reported quarter, Q2 2026, shows −$394.7M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Legend Biotech source filings ↗

Community posts

It’s quiet here.

No posts about LEGN yet. Start the conversation.

Write the first post